Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

699
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
699
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

249
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
249
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

282
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
282
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

216
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
216
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.2K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.2K
Immunofluorescence Microscopy01:12

Immunofluorescence Microscopy

11.6K
A fluorescence microscope uses fluorescent chromophores called fluorochromes, which can absorb energy from a light source and then emit this energy as visible light. Fluorochromes include naturally fluorescent substances (such as chlorophylls) and fluorescent stains that are added to the specimen to create contrast. Dyes such as Texas red and FITC are examples of fluorochromes. Other examples include the nucleic acid dyes 4’,6’-diamidino-2-phenylindole (DAPI), and acridine orange.
11.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Pediatric psoriasis: from immunogenetics to targeted therapies.

Anais brasileiros de dermatologia·2026
Same author

Mammary hidradenitis suppurativa: case series, discussion of differential diagnoses and expanded classification.

Anais brasileiros de dermatologia·2026
Same author

Brief report: A pharmacokinetic study of single-dose periungual methotrexate injections that induced multimonth remission of nail psoriasis in 5 patients.

Journal of the American Academy of Dermatology·2026
Same author

Can food choices be associated with nutritional status and atopic dermatitis severity in children and adolescents?

Nutrition (Burbank, Los Angeles County, Calif.)·2025
Same author

What Clinicians Need to Know About Glucagon-like Peptide 1 Agonists.

The Journal of rheumatology·2025
Same author

Multi systemic compromise due to Bartonella henselae in a child.

Revista do Instituto de Medicina Tropical de Sao Paulo·2025

Related Experiment Video

Updated: Sep 29, 2025

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

272

Immunobiologicals in dermatology.

Dimitri Luz Felipe da Silva1, Elisa Nunes Secamilli1, Mariana Valbon Beleli1

  • 1Discipline of Dermatology, Hospital de Clínicas, Universidade Estadual de Campinas, Campinas, SP, Brazil.

Anais Brasileiros De Dermatologia
|March 22, 2022
PubMed
Summary

Immunobiologicals are crucial for managing inflammatory skin diseases like psoriasis and atopic dermatitis. Dermatologists need to know approved treatments in Brazil for optimal patient care and improved outcomes in chronic conditions.

Keywords:
Arthritis, psoriaticDermatitis, atopicHidradenitis suppurativaPsoriasis

More Related Videos

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
09:42

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research

Published on: April 19, 2017

7.5K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.5K

Related Experiment Videos

Last Updated: Sep 29, 2025

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

272
Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
09:42

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research

Published on: April 19, 2017

7.5K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.5K

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Immunobiologicals are increasingly utilized in clinical practice for inflammatory conditions.
  • Dermatology has seen significant advancements with approved immunobiologicals for conditions such as psoriasis, atopic dermatitis, and hidradenitis suppurativa.
  • Numerous other immunobiological treatments are currently under investigation for various dermatoses.

Purpose of the Study:

  • To highlight the importance of immunobiologicals in dermatology.
  • To inform dermatologists about immunobiological medications approved in Brazil.
  • To emphasize the role of these treatments in managing chronic skin diseases.

Main Methods:

  • Review of approved immunobiologicals in Brazil.
  • Analysis of their application in inflammatory dermatoses.
  • Discussion of their clinical significance.

Main Results:

  • Several immunobiologicals are approved and widely used for psoriasis, atopic dermatitis, and hidradenitis suppurativa.
  • Ongoing research indicates a growing pipeline of immunobiological therapies for dermatological conditions.
  • These treatments offer significant hope for patients with chronic and severe skin diseases.

Conclusions:

  • Immunobiologicals are a vital therapeutic option in modern dermatology.
  • Knowledge of approved treatments in Brazil is essential for effective dermatosis management.
  • These advanced therapies provide a promising outlook for patients suffering from chronic inflammatory skin diseases.